Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with g...
Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
About this item
Full title
Author / Creator
Li, Yao , Zhang, Yanan , Wu, Zeyu and Sun, Peng
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Tropomyosin 4 (TPM4), a member of the tropomyosin family, is aberrantly expressed and plays an important role in a variety of cancers. However, studies on TPM4 in glioma patients are currently lacking.
Our study aimed to evaluate the diagnostic and prognostic characteristics of TPM4 in glioma and its correlation with immune infiltration.
Bioi...
Alternative Titles
Full title
Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5823d8ca4ee54a27a0c48c2d20885a34
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5823d8ca4ee54a27a0c48c2d20885a34
Other Identifiers
ISSN
1471-2377
E-ISSN
1471-2377
DOI
10.1186/s12883-023-03058-0
